The money to fix the underserved areas is here now — and the window to claim it is open.
There is a large pool of public money set aside to pay for opioid treatment in the places that need it most. Opioid-settlement dollars and federal grants build the program; Medicaid pays the recurring bills that keep it running. That money is flowing right now, the grant programs are open, and there is a clear opening before others move. This page answers two questions: who pays, and why now. For the underserved areas themselves, see Treatment Deserts.
Illinois holds hundreds of millions of dollars that, by law, must fund opioid treatment. Settlement payments are arriving, federal grants are open, and Medicaid pays the recurring bill once care is delivered. The money to serve the underserved areas exists today, and the window to win it is open now.
1 · Who pays
Three sources fund treatment in underserved areas, all available at once. Settlement dollars and federal grants pay to build and launch; Medicaid is the recurring payer that keeps the program running for years. Each has its own decision-makers and timing, and delivering treatment is an allowed use of all three.
| Source | Size | Who controls it | Its role |
|---|---|---|---|
| Opioid-settlement dollars | ~$760M+ for Illinois through 2038 verify | The state, counties, and cities | Funds the build and the riskiest early costs through state grants and county contracts |
| Federal grants | The federal rural opioid program (RCORP) up to $750K/yr × 4 yrs; the state's federal opioid-response grant (SOR), ~$36M/yr to Illinois verify | Federal health agencies, often passed through the state | Adds runway for vans, outreach, peer support, and case management |
| Medicaid (the recurring payer) | The largest and most durable source — ongoing, with Medicare alongside it | Medicaid & Medicare | Pays the bills for care once we deliver it — the engine that runs after grants end |
How Illinois spends its settlement money
Illinois splits its settlement money three ways: about 55% into a competitive grant fund for opioid remediation, about 20% to state-agency programs, and about 25% straight to local governments. The competitive fund had already received $299M as of June 2026 and can spend up to $44M per year verify. Money is moving into funded programs right now.
The fastest money is the share paid straight to counties — the local quarter or so of the settlement. Counties buy services directly, and a signed contract can close in 60 to 120 days, far faster than a state grant cycle. The federal rural opioid program (RCORP) is open now, with applications due July 8, 2026, up to $750K a year for four years, with for-profit leads eligible. The state's federal opioid-response grant (SOR) adds more, accessed as a state subrecipient. The full set of grants and which costs each one covers is on Funding the Build.
2 · Medicaid: the engine after grants end
Grants build the program, but they run out. The durable payer is Medicaid — the main source of patient volume in addiction treatment — with Medicare alongside it (covering addiction-treatment services since 2020). Once care is delivered, these payers fund it year after year.
The economics work because medication alone is low-margin, but wrapping it in billable behavioral-health care — psychiatric medication management, therapy, intensive outpatient programs, case management, and peer support — roughly doubles the value per patient and keeps people in treatment longer.
| Value per patient | Per year | Over a lifetime |
|---|---|---|
| Medication only | ~$2,590 | ~$3,370 |
| Medication + behavioral health | ~$6,640 | ~$16,600 |
| How much behavioral health lifts the value | ~2.6× | ~4.9× |
Settlement and federal grants cover the van, medications, outreach, and the riskiest early costs. Recurring Medicaid and Medicare billing then funds the durable core — so the program pays its own way long after the grants are spent. The full breakdown is on the Financial Model.
3 · Why now
Three things line up for a 24-to-36-month window, and all three are temporary.
Settlement funds are arriving, not just promised
New settlement payments — Purdue/Sackler (about $148.8M for Illinois), Kroger (about $40M), and Mallinckrodt (about $36M) verify — are driving spending decisions now. Illinois is actively funding programs this cycle.
Live programs, on a clock
The federal rural opioid program is open with applications due July 8, 2026. County direct-share contracts can close in 60 to 120 days. These are open today, not someday — and grant rounds close.
The old barriers came down
A 2023 federal law removed the special permit doctors once needed to prescribe buprenorphine, so we can start prescribing and billing within weeks. Updated 2026 privacy rules brought addiction-treatment records in line with general health-record rules, simplifying coordinated care.
The bottleneck in this market is not money and not demand — it is being a licensed, trusted provider that can deliver care and bill for it. New entrants spend about a year getting licensed and enrolled with insurers before treating a single patient. We are already past that point, so we can win this funding while the window is open and others are still getting started.
The bottom line
The money to serve the underserved areas is real, allowed for treatment, and arriving now. Settlement dollars and federal grants build the program; Medicaid runs it for years afterward. The grants are open, the funds are flowing, and there is a clear opening before others move. This is a 24-to-36-month window to turn public funding into a treatment network that pays its own way. For where that need is concentrated, see Treatment Deserts; for the full grant stack and cost coverage, see Funding the Build.